LL-37(13-37)
General Information
DRACP ID DRACP00156
Peptide Name LL-37(13-37)
Sequence IGKEFKRIVQRIKDFLRNLVPRTES
Sequence Length 25
PubChem CID 102602726
Origin LL-37,a series of peptide fragments
Type Synthetic peptide
Classification
Active ACP Induce apoptosis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
KBv | Human oral carcinoma | Carcinoma | LC50=39 µM | MTT assay | 24 h | 1 |
KB | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | LC50=40 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity HBMEC: LC50=38±3 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C137H232N42O36
Absent amino acids ACHMWY
Common amino acids R
Mass 347186
Pl 11.58
Basic residues 7
Acidic residues 3
Hydrophobic residues 9
Net charge 4
Boman Index -7724
Hydrophobicity -62.4
Aliphatic Index 101.2
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16637646
Title Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region
Year 2005
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code